References:
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72 314 Cases From the Chinese Center for Disease Control and
Prevention. JAMA. 2020;323(13):1239-1242.
- Yuan S. Statins May Decrease the Fatality Rate of Middle East
Respiratory Syndrome Infection. mBio. 2015;6(4):e01120-15.
- DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guardeño JM,
Fernandez-Delgado R, Fett C, et al. Inhibition of NF-κB_-Mediated
Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected
Mice Increases Survival. Journal of Virology. 2014;88(2):913.
- Cimato TR, Palka BA. Effects of statins on TH1 modulating cytokines in
human subjects. PeerJ. 2015;3:e764.
- Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD
mortality protection as pleiotropic, dose-dependent effects of
statins. Chest. 2007;131(4):1006-12.